Kataloge von Innaxon
Compounds powered by Lipodisq™
Lipodisq™ are novel lipid/polymer nanoparticles that have been developed as mimics of naturally-occurring high-density lipoproteins (HDL). Lipodisq™ particles are in the size range of 11 to 40 nm in diameter enabling enhanced penetration and diffusion into membranes. These nanodisc lipid particles are composed of a hydrophilic shell and hydrophobic core, in which hydrophobic active agents can be carried and protected. Released October 2022.
Innaxon - Bringing Innate Immunity to Life!
Innaxon develops and manufactures defined “Immunoceuticals” of the highest activity and purity for pre-clinical research and development applications for vaccine adjuvants and immunotherapy. Their unique biological and synthetic Toll-like Receptor (TLR) ligands are well-characterized and effective biological response modifiers of inappropriate or disproportionate immune responses. Released October 2022.
TLR4 Agonist Arrays
Facilitate the determination of the optimal cell density, time point of analysis and multiplexing of readouts (e.g. cytokine(s) ELISA) of TLR4 specific cellular activation in a highly reproducible and safe procedure. Released November 2014.